ConvaTec Regulatory News (CTEC)

ConvaTec Group Plc

Board Committee Changes

Reading, United Kingdom - 27 January 2022

ConvaTec Group Plc ("ConvaTec" or "the Company") is pleased to announce that Professor Constantin Coussios, a Non-Executive Director of the Company, has today been appointed as a member of the Company's Remuneration Committee and Nomination Committee.

This announcement is made in accordance with Listing Rule 9.6.11R (3).

Enquiries:

Analysts and Investors

Kate Postans, Vice President, Investor Relations +44(0)7826 447 807

ir@convatec.com

Media

Buchanan: Chris Lane +44(0)207 466 5000

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec Group PlcConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com